Floor J. Mansvelder

Ms. Floor J. Mansvelder

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
SBSebastiaan M. Bossers
Sebastiaan M. Bossers
FMFloor J. Mansvelder
Floor J. Mansvelder
SLStephan Alexander Loer
Stephan Alexander Loer
CBChrista Boer
Christa Boer
FBFrank W. Bloemers
Frank W. Bloemers
FKFabian O. Kooij
Fabian O. Kooij
Purpose Severe traumatic brain injury is a leading cause of mortality and morbidity, and these patients are frequently intubated in the prehospital setting. Cerebral perfusion and intracranial pressure are influenced by the arterial partial pressure of CO2 and derangements might induce further brain damage. We investigated which lower and upper limits of prehospital end-tidal CO2 levels are associated with increased mortality in patients with severe traumatic brain injury. Methods The BRAIN-PROTECT study is an observational multicenter study. Patients with severe traumatic brain injury, treated by Dutch Helicopter Emergency Medical Services between February 2012 and December 2017, were included. Follow-up continued for 1 year after inclusion. End-tidal CO2 levels were measured during prehospital care and their association with 30-day mortality was analyzed with multivariable logistic regression. Results A total of 1776 patients were eligible for analysis. An L-shaped association between end-tidal CO2 levels and 30-day mortality was observed (p = 0.01), with a sharp increase in mortality with values below 35 mmHg. End-tidal CO2 values between 35 and 45 mmHg were associated with better survival rates compared to < 35 mmHg. No association between hypercapnia and mortality was observed. The odds ratio for the association between hypocapnia (< 35 mmHg) and mortality was 1.89 (95% CI 1.53–2.34, p < 0.001) and for hypercapnia (≥ 45 mmHg) 0.83 (0.62–1.11, p = 0.212). Conclusion A safe zone of 35–45 mmHg for end-tidal CO2 guidance seems reasonable during prehospital care. Particularly, end-tidal partial pressures of less than 35 mmHg were associated with a significantly increased mortality.

8 January 2024 in Anesthesiology
Verified
Journal Article
Open access
PDF file
FMFloor J. Mansvelder
Floor J. Mansvelder
SBSebastiaan M. Bossers
Sebastiaan M. Bossers
SLStephan A. Loer
Stephan A. Loer
FBFrank W. Bloemers
Frank W. Bloemers
ELEsther M. M. Van Lieshout
Esther M. M. Van Lieshout
FCFor The Brain-Protect Collaborators
For The Brain-Protect Collaborators
Background: Severe traumatic brain injury is a leading cause of morbidity and mortality among young people around the world. Prehospital care focuses on the prevention and treatment of secondary brain injury and commonly includes tracheal intubation after induction of general anesthesia. The choice of induction agent in this setting is controversial. This study therefore investigated the association between the chosen induction medication etomidate versus S(+)-ketamine and the 30-day mortality in patients with severe traumatic brain injury who received prehospital airway management in the Netherlands. Methods: This study is a retrospective analysis of the prospectively collected observational data of the Brain Injury: Prehospital Registry of Outcomes, Treatments and Epidemiology of Cerebral Trauma (BRAIN-PROTECT) cohort study. Patients with suspected severe traumatic brain injury who were transported to a participating trauma center and who received etomidate or S(+)-ketamine for prehospital induction of anesthesia for advanced airway management were included. Statistical analyses were performed with multivariable logistic regression and inverse probability of treatment weighting analysis. Results: In total, 1,457 patients were eligible for analysis. No significant association between the administered induction medication and 30-day mortality was observed in unadjusted analyses (32.9% mortality for etomidate versus 33.8% mortality for S(+)-ketamine; P = 0.716; odds ratio, 1.04; 95% CI, 0.83 to 1.32; P = 0.711), as well as after adjustment for potential confounders (odds ratio, 1.08; 95% CI, 0.67 to 1.73; P = 0.765; and risk difference 0.017; 95% CI, −0.051 to 0.084; P = 0.686). Likewise, in planned subgroup analyses for patients with confirmed traumatic brain injury and patients with isolated traumatic brain injury, no significant differences were found. Consistent results were found after multiple imputations of missing data. Conclusions: The analysis found no evidence for an association between the use of etomidate or S(+)-ketamine as an anesthetic agent for intubation in patients with traumatic brain injury and mortality after 30 days in the prehospital setting, suggesting that the choice of induction agent may not influence the patient mortality rate in this population. Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New:

22 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MSMagnus Strypet
Magnus Strypet
CBCaitlin Bozic
Caitlin Bozic
FMFloor J. Mansvelder
Floor J. Mansvelder
JBJennifer S. Breel
Jennifer S. Breel
EJEvert K. Jansen
Evert K. Jansen
SESusanne Eberl
Susanne Eberl
Background/Objectives: Recent studies show conflicting results regarding sex-related differences in outcomes following aortic surgery. This study primarily evaluated 20-year mortality rates, along with 30-day and one- and five-year rates, and postoperative complications in female and male patients who underwent elective and acute ascending aortic surgery at a tertiary care centre. Methods: This retrospective observational study analysed data from 676 adult patients who underwent ascending aortic surgery in Amsterdam UMC, between January 2001 and December 2020. Descriptive statistics, Fisher’s Exact test, Kaplan–Meier survival analysis, and logistic regression were used to assess differences in mortality rates. Results: Patient characteristics for elective and acute procedures were different. Females were generally older (elective: 69 vs. 62 years, p < 0.001, acute: 70 vs. 62 years, p = 0.002), with smaller body surface area (elective/acute: 1.8 vs. 2.1 m2, p < 0.001), lower preoperative haemoglobin (elective: 8.3 vs. 8.9 mmol/L, p < 0.001, acute: 7.8 vs. 8.4 mmol/L, p < 0.001) and estimated glomerular filtration rate (elective: 64 vs. 91 mL/min, p < 0.001; acute: 67 vs. 83 mL/min, p = 0.004). Females undergoing elective procedures had a lower body mass index (25.0 vs. 26.6 kg/m2, p = 0.006), better left ventricle function (p = 0.048) and higher incidence of chronic obstructive pulmonary disease (15 vs. 8%, p = 0.032). In elective procedures, the 20-year mortality rate (49% vs. 30%, p < 0.001) was significantly higher in females, especially those under 60 years (OR of 3.158 [1.2–8.6], p = 0.024). Mortality rates up to one year were comparable. Five-year mortality rate (26% vs. 16%, p = 0.027) was higher. Females had longer ventilation times (32% vs. 15%, p < 0.001) and intensive care unit stays (2 vs. 1 days, p = 0.005). For acute procedures, morbidity and mortality rates were comparable between sexes. Conclusions: Females under 60, undergoing elective ascending aortic surgery showed higher long-term all-cause mortality rates. Implementing sex-specific management strategies and extended follow-up could be essential for improving outcomes in this group.

21 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CBCaitlin Bozic
Caitlin Bozic
MSMagnus Strypet
Magnus Strypet
FMFloor J. Mansvelder
Floor J. Mansvelder
EJEvert K. Jansen
Evert K. Jansen
JBJennifer S. Breel
Jennifer S. Breel
SESusanne Eberl
Susanne Eberl
Background: Sex-related differences in outcomes following cardiac surgery are well documented, with females generally experiencing higher postoperative mortality rates than males. However, the underlying factors driving this disparity remain incompletely understood. This study aimed to compare the preoperative risk characteristics of female and male patients who died within one year after elective cardiac surgery with those who survived, in order to identify sex-specific risk profiles associated with postoperative mortality. Methods: In this retrospective single-centre cohort study, data were derived from a prospective quality assurance database at Amsterdam University Medical Centres (Amsterdam UMC), The Netherlands, covering January 2001 to December 2020. All adult patients (≥18 years) undergoing elective cardiac surgery were included. Descriptive and comparative analyses were performed to characterise sex-specific preoperative differences between survivors and non-survivors. Results: The study cohort comprised 10,614 patients, including 2804 females (26%; median age 72 years [IQR 65–77]) and 7810 males (74%; median age 67 years [IQR 59–73]). In both sexes, non-survivors more frequently had major comorbidities, including atrial fibrillation, history of reoperation, pulmonary hypertension, chronic obstructive pulmonary disease, cerebrovascular disease, and kidney dysfunction. Within one year post-surgery, 143 (5.1%) females and 299 (3.8%) males had died. Among females, non-survivors within one year of surgery more frequently had several preoperative risk factors compared with survivors, including moderately impaired left ventricular function (16% vs. 11%), pulmonary hypertension (12% vs. 3%), extracardiac arteriopathy (25% vs. 9%), and kidney dysfunction (46% vs. 21%) dependent on the type of surgery (combined valve + coronary artery bypass grafting (CABG) (29% vs. 15%) or aortic surgery (14% vs. 4%)). In male patients, however, different risk factors such as higher age (median 73 years [IQR 66–77] vs. 67 [59–73]), lower Body Surface Area (mean 1.96 m2 (SD ± 0.19) vs. 2.02 ± 0.18), hypercholesterolaemia (35% vs. 44%), severely impaired left ventricular function (14% vs. 6%), myocardial infarction (31% vs. 22%), and type of surgery (aortic surgery (9% vs. 3%), or combined valve + CABG (22% vs. 12%)) were preoperative predictors of mortality compared to non-survivors. Conclusions: Our study demonstrates that one-year mortality following elective cardiac surgery is driven by distinct preoperative risk profiles in females and males. Recognising that mortality in females is associated with systemic disease and males by direct cardiac damage is a critical step toward developing more equitable, precise, and effective perioperative management strategies.

24 April 2026 in Neurocritical Care
Verified
Journal Article
Open access
PDF file
EBElise Beijer
Elise Beijer
FMFloor J. Mansvelder
Floor J. Mansvelder
RDRomein Willem Gerben Dujardin
Romein Willem Gerben Dujardin
NJNicole Juffermans
Nicole Juffermans
LSLinda J. Schoonmade
Linda J. Schoonmade
PSPatrick Schober
Patrick Schober
Traumatic brain injury (TBI) is a major cause of trauma-related mortality. While male individuals are disproportionately affected, the influence of sex on mortality remains controversial, with conflicting evidence suggesting female advantage, disadvantage, or no difference. Clarifying this relationship is crucial for prognosis and sex-specific treatment. A systematic search was conducted on 4 June 2025 in PubMed, Embase, Web of Science, and the Cochrane Library without date restrictions. Observational studies reporting sex-stratified TBI patient mortality with sufficient data to derive effect sizes were included. Screening, full-text assessment, and data extraction were performed independently by multiple reviewers. Random-effects meta-analysis was conducted to calculate odds ratios (OR) for mortality in female versus male individuals, with subgroup and leave-one-out sensitivity analyses as well as meta-regression. Heterogeneity was quantified using I 2 and prediction intervals. Quality was assessed using an adapted Newcastle–Ottawa Scale. The review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. A total of 40 studies, encompassing over 1 million patients (383,914 female individuals; 662,748 male individuals), were included. Overall, sex was not significantly associated with TBI mortality [OR 0.99; 95% confidence interval (CI) 0.90–1.09], though substantial between-study heterogeneity and prediction intervals indicated that female mortality could be higher in some contexts and lower in others. Subgroup analyses showed no significant differences by TBI type, age, or severity. Although initial analyses suggested lower female mortality in good-quality studies and higher female mortality in patients with severe TBI and in studies conducted before the 2000s, the findings were not robust in leave-one-out analyses. Meta-regression indicated that mean age differences did not explain heterogeneity between sex and mortality estimates. Concluding, there is no universal biological association between sex and TBI mortality. Instead, the relationship appears context-dependent, varying by study characteristics and patient populations. Future research should move beyond assessing sex as a simplistic risk factor and focus on identifying specific biological and clinical contexts where sex influences outcomes to inform personalized care.

1 April 2026 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
ABAnne Maria Beukers
Anne Maria Beukers
FMFloor J. Mansvelder
Floor J. Mansvelder
SESusanne Eberl
Susanne Eberl
HHHenning Hermanns
Henning Hermanns
Protamine dosing in cardiac surgery: method is key